Background. Cardiopulmonary bypass (CPB), a process routinely used during cardiac surgery, is a potent stimulant to the release of endogenous catecholamines. Hence, we tested the hypothesis that CPB results in myocardial P-adrenergic receptor (PAR) desensitization.
epinephrine (NE) have been repeatedly documented.1-7 The highest catecholamine levels tend to occur late in the course of CPB, when the heart and lungs are excluded from the circulation and while the patient is being rewarmed1-4; circulating catecholamines return toward baseline after CPB. 1, 248 During CPB (specifically aortic crossclamping), the myocardium is cooled, arrested, and deprived of its native blood flow. Under similar conditions, release of NE has been demonstrated from anoxic, isolated hearts, 9-12 and cooling maintains elevated catecholamines in ischemic myocardium. 13, 14 In addition, elevated coronary sinus NE and epinephrine are observed during reperfusion.15 Hence, upon termination of CPB, increased catecholamine levels may have been experienced locally within myocardial tissue, and the rewarmed uncrossclamped heart is exposed to blood containing markedly elevated circulating catecholamines.
Discontinuation of CPB is an extremely critical event during cardiac surgery, and depressed myocardial performance during this time period may result in an inability to be weaned from CPB. Because continuous exposure to catecholamines has been shown to desensitize 18-adrenergic receptors (J3ARs),16"7 we hypothesized that myocardial ,3AR desensitization might occur during CPB. This may be important clinically because flAR agonists may need to be infused in those patients in whom adequate cardiac output cannot be achieved upon termination of CPB (secondary to a relative lack of /3AR-mediated myocardial inotropic responses). [18] [19] [20] [21] To test the hypothesis that ,BAR desensitization occurs during CPB, we obtained canine transmyocardial biopsies before, during, and after CPB and determined ,AR density, proportion of 81AR versus /32AR, and ,BAR functional coupling to adenylyl cyclase.
Methods

Experimental Protocol
All experiments involving animals conform to the guiding principles of the American Physiological Society. After institutional approval, 12 dogs weighing 22-26 kg were anesthetized with thiopental (15-25 mg/kg i.v.) and placed supine. Normocarbic ventilation was established using 100% oxygen through an endotrachial tube, and halothane anesthesia was briefly used for placement of monitors and sternotomy. Arterial blood gas analysis, arterial plasma catecholamine levels, and aortic blood pressure were monitored with a pressure-transducertipped catheter inserted into the femoral artery and advanced to the thoracic aorta; plasma catecholamine determinations were performed using high performance liquid chromatography as previously described. 22 After sternotomy, halothane was discontinued, and an anesthetic typically used for cardiac surgery in humans was instituted (boluses of fentanyl [5-10 ,ug /kg] and midazolam [50 ,ug/kg], followed by continuous infusions [fentanyl 0.1-0.2 ,ug/kg/min and midazolam 1-2 ,g/kg/min]) for the rest of the experiment.
The timing of myocardial biopsies is illustrated in Figure 1 . CPB was designed to mimic typical bypass occurring during cardiac surgical procedures in humans. The biopsies were transmyocardial, including both epicardium and endocardium. They were obtained in the anatomically identical place in the apex of the left ventricle (LV) with a 7F Tru-cut biopsy needle. At each time point, four biopsies (each weighing 15-20 mg, total 60-80 mg wet weight) were obtained, immediately frozen in liquid nitrogen, and stored at -70°C. Studies in our laboratory showed that these small biopsies do not induce altered ventricular function. In order to ensure a stable baseline preparation after surgical manipulations, 90 minutes passed before CPB. Baseline myocardial biopsies (designated 4"pre-CPB") were obtained before initiation of CPB. After heparin administration (300 units/kg), nonpulsatile CPB was instituted by draining the venous blood from the right atrium and returning the arterialized blood into the proximal left subclavian artery; flow rate was set at 1.7 1/min/m2, and mean arterial blood pressure was held constant at 55-65 mm Hg. Paco2 was maintained at 30-40 mm Hg, Pao2 at 100-200 mm Hg, and pH at 7. 35-7.45 . After the dog was stabilized at a body temperature of 28-32°C for 90 minutes, the aorta was crossclamped and the heart arrested by an initial dose (350 ml) of cold (4°C) cardioplegia solution (Na= 120 meq/l, K=16 meq/l, Ca=2.4 meq/l, Mg=32 meq/l, Cl=160 meq/l, HCO3=20 meq/l, hep-arin= 1,000 units/1, procainamide= 150 mg/l, osmola-lity=300 mosm/l, pH=7.80 at 4°C) infused into the aortic root. The heart was packed in crushed ice, and myocardial septal temperature was maintained between 14 and 18°C. After 20 minutes, a second dose of cardioplegia solution (250 ml) was infused. The aortic crossclamp was released after 40 minutes, and rewarming was begun. After 25 minutes of rewarming (155 minutes after initiation of CPB), a stable body temperature of 36°PC was achieved, and myocardial biopsies (designated "CPB") were obtained as described above. The dogs were then weaned from CPB, and the right atrium was decannulated and stabilized at an LV end-diastolic pressure of 5-8 mm Hg with volume (no inotropic agents were used). Thirty minutes after CPB, myocardial biopsies (designated "post-CPB") were obtained as described above. 11 Five additional dogs served as a control group. An identical protocol was followed (including transmural myocardial apical biopsies) with the exception of CPB. In addition, an extra myocardial apical biopsy was performed in these dogs immediately after sternotomy. Hence, these dogs served as controls for time and anesthesia.
Sample Preparation
Frozen canine myocardial biopsy samples were thawed in ice-cold lysis buffer (10 mM Tris, 5 mM EDTA; pH 7.40 at 4°C) and homogenized in 1 ml lysis buffer with a Brinkman polytron at 50% maximal speed for 8 seconds. The lysis buffer, as well as all subsequent buffers described for ligand binding or adenylyl cyclase assays, contained the protease inhibitors benzamidine (10 ,ug/ml), leupeptin (5 ug/ml), and soybean trypsin inhibitor (10 gg/ml). After homogenization, the particulate suspension was diluted 15-fold in lysis buffer and centrifuged at 30,000g for 20 minutes at 4°C. The pellet was resuspended in 75 mM Tris, 5 mM MgCl2, and 2 mM EDTA (pH 7.40 at 37°C) buffer and filtered through one layer of 100-,m nylon mesh to remove occasional clumps.
Radioligand Binding P3AR radioligand binding was performed with [1"I]-iodocyanopindolol (ICYP) by methods similar to those we have previously described for skeletal muscle,23 lung,24 and cultured cells.25 Briefly, for saturation binding studies, membranes (-30 ,ug) were incubated with various concentrations of ICYP (5-300 pM) in the absence (total binding) or presence (nonspecific binding) of 100 ,uM isoproterenol for 2 hours at 25°C. For this and other ligand binding studies, GTP (100 ,uM) was included in the incubations to eliminate any retained agonist binding. Reactions were terminated by rapid vacuum filtration over glass fiber filters (GF/C), which were subsequently washed three times with ice-cold 10 mM Tris buffer. Filters were counted in a gamma counter at 70% efficiency. To assess the proportion of I31AR versus /32AR present in canine ventricle, competition assays were performed in duplicate with 15 concentrations (10-4_10-11 M) of the relatively f31AR-selective antagonist ICI89.406 in the presence of 60 pM ICYP. Reaction conditions were as above.
Adenylyl Cyclase Activities
Canine ventricular membrane adenylyl cyclase activities were assessed by the method of Salomon26 as modified and described previously.25'27-29 Samples (-60 ,ug) were incubated in triplicate with various agents in a reaction mixture consisting of 30 mM Tris, 2 mM MgCl2, 0.8 mM EDTA, 0.8 mM ascorbic acid (for catecholamine oxidation protection), 0.12 mM ATP, 0.06 mM GTP, 2.8 mM phosphoenolpyruvate, 50 ,ug/ml myokinase, 0.1 mM cAMP, and 5 ,uCi of a[32P]ATP in a final volume of 50 gl for 30 minutes at 37°C. The final free Mg2+ concentration in these reactions was -1 mM. Reactions were performed in the presence of water (basal), various concentrations of isoproterenol, or the selective f32AR agonist zinterol.
[32P]cAMP was isolated by sequential chromatography over 1.0 ml Dowex and alumina columns. Individual column recovery of [32P]cAMP was normalized on the basis of recovery of a known amount of [3H]cAMP added to the stop buffer; routine recovery was approximately 75-80%. Samples were eluted off the alumina columns with 0.1 M imidazole into 15 ml of scintillation cocktail and counted with a dual-channel liquid scintillation counter. Under these conditions, accumulation of [32P]cAMP was linear with time, temperature, and protein. No significant depletion of ATP substrate was present, and phosphodiesterase activity was totally suppressed by the unlabeled cAMP. Preliminary studies (see below) using full isoproterenol dose-response curves revealed half-maximal adenylyl cyclase stimulation at a concentration of -500 nM and maximal stimulation at 50-100 LM. Therefore, because of the paucity of membrane material available, triplicate determinations of basal, submaximal (500 nM isoproterenol to assess any shift in potency), and maximal (100 ,uM) isoproterenol-stimulated adenylyl cyclase activities were performed in samples from study dogs. Maximal zinterol-stimulated adenylyl cyclase activities were significantly less (-50%) than those for maximal isoproterenol, and a submaximal stimulation was often difficult to detect, so only the maximal response to zinterol (100 ,uM) was determined.
Data Analysis
Data from radioligand binding assays and adenylyl cyclase dose-response studies were analyzed by nonlinear iterative least-squares techniques.30-31 For 1C189.406 competition curves, data fit poorly to a one-site model as expected, with Hill coefficients significantly less than 1.0. Data were therefore fit to a two-site model, as given by the following equation32: Bmaxj3l Bmax0 maTL+ kd,pl (1+ /ki,pl) L+ kdp2'(1 + /kip32) where BmaT is the total amount of radioligand bound, Bma.,, and Bm.2 are the densities of the fl1AR and ,32AR, L is the concentration of ICYP used, I is the concentration of competing ligand (such as 1C189.406), kd,61 and kd,2 are the dissociation constants for ICYP binding to 81AR and 32AR, and kip, and ki2 are the dissociation constants for the inhibition of ICYP binding to f31AR and /32AR by the competing ligand. The twofold greater selectivity of ICYP for the /32AR as compared to the /31AR was taken into account. 32 The "goodness of fit" was assessed by the relative distance method, and R2 was greater than 0.950 for all curves. Both receptor densities and adenylyl cyclase activities were normalized to protein, which was measured by the copperbicinchoninic acid method.33 Comparisons were made with paired two-tailed Student's t tests as indicated. Data are presented as mean+SEM. Ligand binding properties and adenylyl cyclase activities of canine left ventricular (apical) biopsies obtained from three to six individual dogs during preliminary investigations. Conditions were identical to those described for pre-CPB (see text). IC189.406 is a ,81AR-selective antagonist and zinterol is a ,2AR-selective agonist. 
Materials
Analysis of ligand binding and adenylyl cyclase data was performed as described above using the computer programs LIGAND and ALLFIT (gifts from P.J. Munson, NIH) and INPLOT Table 1 summarizes the pharmacological properties of ,lAR from canine LV biopsies. The receptor density found (113+6 fmol/mg) is similar to that reported for human34,35 and guinea pig36 LV, lower than that reported for lamb LV (-300 fmol/mg37), and higher than that generally reported for rat LV (-25 fmol/mg38). It is also somewhat higher than the -60 fmol/mg that has been previously reported for canine LV membranes. 39 The kd for ICYP is typical of that reported by others as listed above. In preliminary studies, we found a ratio of 56:44 for 131AR: I32AR in canine LV, using ICYP competition binding studies with the selective 131AR antagonist 1C189.406 (Table 1, Figure 2 ). The -1,000-fold greater affinity of ICI89.406 for the ,13AR versus the p2AR (Table 1) edly high proportion of P2AR that we found in canine LV, we performed preliminary studies with two additional selective antagonists, 1C1118.551 (/32AR selective) and betaxolol (j61AR selective). These studies also revealed similar proportions of 813AR: p2AR (data not shown). The approximately 2.5-fold maximal stimulation over basal of adenylyl cyclase activity by isoproterenol, with an EC50 of -500 nM, is typical of myocardial membranes from a number of species. 35, 36 We also considered several methods by which to assess the relative contributions of f3IAR versus f32AR to agonist-stimulated adenylyl cyclase activities. Prenalterol, a relatively specific P31AR partial agonist, however, stimulated canine LV membrane adenylyl cyclase activities minimally (--10%), and we therefore did not consider this an appropriate agent to assess the relative subtype contribution. Zinterol, on the other hand, a relatively selective P2AR agonist, provided a 50% increase in adenylyl cyclase activity over basal in these membranes ( Table 1 ). In U937 cell membranes, which we have previously shown to have exclusively P2AR,42 zinterol demonstrated partial agonist properties, providing -40% of the stimulation obtained by the full agonist isoproterenol. In addition, in canine LV membranes, zinterol stimulation was not blocked by 10`7 M 1C189.406 in this mixed-subtype preparation. Thus, as also recently concluded by Bristow et al,35 the use of zinterol appears to provide an accurate assessment of the relative contribution of I82AR agonist-stimulated adenylyl cyclase activities in a mixed population of PI1AR and 32AR. Interestingly, the stimulation of canine LV adenylyl cyclase by zinterol amounts to -50% of the maximal activity achieved by isoproterenol ( Table 1 ). Noting that ,32AR represents less than one half of the receptors and that zinterol is only a partial agonist, it thus appears that the f32AR is more strongly coupled to sentative dog during the entire study protocol. Arrows denote the beginning and end of cardiopulmonary bypass (CPB) (see Figure 1 for other associated events). After a transient increase in catecholamine levels associated with surgical manipulations at the beginning of the protocol, basal levels of catecholamines resumed (within 15 minutes) until CPB, when significant increases in plasma epinephrine and norepinephrine levels occurred. Although trending downward, plasma catecholamines did not decrease significantly by 30 minutes post-CPB.
Characterization of Canine Myocardial J3AR
In control dogs where CPB was not initiated, catecholamine levels did not change from basal over the same time period.
adenylyl cyclase in this system, a situation similar to that recently reported in human LV. 35 Effects of CPB on Plasma Catecholamines Figure 3 shows arterial plasma catecholamine levels (epinephrine and NE) from a representative dog during the entire study protocol. A transient increase in catecholamine levels associated with surgical manipulations occurs at the beginning of the protocol, quickly followed by a return to basal levels until CPB. During CPB, significant increases in plasma epinephrine levels (310±119 to 2,214±713 pg/ml, p<0.05) and NE levels (254±19 to 1,835+379 pg/ml,p<0.01) were seen over time. Although trending downward, plasma catecholamines did not decrease significantly by 30 minutes post-CPB. Of note, in control dogs where CPB was not initiated, catecholamine levels did not change significantly from basal over the same time period. To the best of our knowledge, this represents the first description of catecholamine levels during CPB in a canine model and agrees in magnitude (sevenfold) with increases in catecholamine levels occurring during CPB in humans.1-7
Effects of CPB on Cardiac 3A4Rs
In control dogs not exposed to CPB, canine LV PAR density did not change at time points corresponding to pre-CPB (93±5 fmol/mg), CPB (101±7 fmol/mg), and post-CPB (100±5 fmol/mg). These values for canine LV ,BAR density in control dogs were the same as an additional biopsy done in control dogs immediately upon opening of the chest at the beginning of the protocol. In addition to a lack of change in canine LV 83AR density in control dogs, functional properties of these receptors (as demonstrated by agonist-stimulated adenylyl cyclase activity) also did not change. In control dogs, maximal isoproterenol (100 gM) -stimulated activities were not significantly different at any time point including immediately upon opening the chest (223 ± 62 pmol/30 min/mg) and at matched time points corresponding to pre-CPB (264±26 pmol/30 min/mg), CPB (322±130 pmol/30 min/mg), and post-CPB (201±45 pmol/30 min/mg). Similar results (no change from baseline) were also noted in submaximal isoproterenol (500 nM) -stimulated adenylyl cyclase activities in control dogs. In dogs exposed to CPB as shown in Figure 4 , the density of 83ARs on canine LV membranes decreased at the post-CPB time point from 112±14 to 84±7 fmol/mg,p<0.05. The proportion of f31AR: f32AR was unchanged (60±3:40±3 to 61±2:39±2). When the individual receptor densities of J31AR and p2AR are calculated on the basis of the proportions and the total Bmax it appears that both 13IAR (66±9 to 52±5 fmol/mg) and f2AR (45±6 to 32±3 fmol/mg) densities are decreased at this time point. The receptor densities during CPB, while showing a downward trend (112+14 to 103±9 fmol/mg total, 66±9 to 58±6 fmol/mg f31AR, and 45+6 to 46±5 fmol/mg ,82AR) did not reach statistical significance ( Figure  4) , and no changes in the J31AR: J2AR ratio (60±3:40±3 to 55+3:44+3) were noted. An entirely different pattern was noted in the functional properties of these receptors during CPB. As shown in Figure 5 min/mg (p<0.05). Submaximal isoproterenol-stimulated adenylyl cyclase activities were also depressed during CPB, decreasing from 183+10 to 157±11 pmol/30 min/mg (p<0.05). In a similar fashion, zinterol-stimulated adenylyl cyclase activities were decreased from 188±11 to 159±11 pmol/30 min/mg (p<O.05). This time point represents the period when depressed myocardial inotropic responses are found clinically during attempts to wean from CPB ( Figure  1) . Notably, however, this desensitized pattern was found to be completely reversed at the final time point (post-CPB), with all adenylyl cyclase activities returning to pre-CPB levels or slightly higher (maximal isoproterenol 268 ±22 pmol/30 min/mg, submaximal isoproterenol 207±20 pmol/30 min/mg, and maximal zinterol 223±18 pmol/30 min/mg; p=NS compared to pre-CPB). Discussion Adrenergic receptors are subject to dynamic regulation by a variety of mechanisms.43,44 One of the most intensively studied of these mechanisms is desensitization, also referred to as tachyphylaxis or refractoriness. Desensitization is a common phenomenon observed in a diverse group of signal transduction systems and refers to dampening of a biologic response during continuous exposure to a stimulus.1617 At the cellular level in the 83AR receptor system, this is observed as a decrease in agoniststimulated intracellular content of the second messenger cAMP or in membrane assays as a decrease in the agonist-stimulated activity of the enzyme that catalyzes cAMP formation, adenylyl cyclase. Desensitization has been observed during chronic ,lAR agonist therapy and with some pathologic conditions.44 Three associated processes have been described to occur during agonist-promoted ,BAR desensitization. The earliest process is a rapid (seconds to minutes) uncoupling of the receptor from the stimulatory guanine nucleotide protein (GQ), which then leads to dampened adenylyl cyclase activity. The hallmarks of this uncoupling are phosphorylation of the receptor by either the cAMP-dependent protein kinase or the ,AR kinase. During more prolonged exposure to agonist (hours), the total cellular fAR complement decreases, a phenomenon referred to as downregulation. It is not uncommon to find receptor density reduced by -80% after 24 hours of agonist exposure in some systems; agonist-stimulated adenylyl cyclase activities are also often profoundly depressed. Another process, whose role in agonistinduced desensitization is not yet defined with certainty, is the redistribution of receptors from the cell surface to a compartment (presumably intracellular) not accessible to agonists. This is referred to as sequestration or internalization, and it occurs during brief (minutes) exposure to agonist. In whole cell assays, this can be assessed using hydrophilic and hydrophobic ligands. In membrane preparations, sequestered receptors may be lost in the supernatants of the centrifugation process, with the resulting receptor density of plasma membranes found to be decreased. It should be emphasized that desensitization is a functional term as defined above, and may not specifically require the presence of any one of the three above-mentioned processes. Likewise, the existence of one process, such as downregulation, may not necessarily result in desensitization.
We hypothesized that alterations in cardiac /3ARs might occur during CPB, a process known to be associated with high catecholamines. Because CPB has previously been shown to be associated with depressed myocardial inotropic responses'8-21 and therapeutic adrenergic agonists are not infrequently used during discontinuation of CPB, desensitization of myocardial ,BAR may be important clinically. Because it is impossible to examine functional responsiveness to exogenously administered catecholamines and concurrently measure myocardial PAR desensitization caused solely by CPB, we chose to concentrate on a detailed analysis of changes in myocardial f3ARs during CPB at the cellular level.
This study was designed to evaluate several possible alterations in 83ARs known to be associated with desensitization. One alteration that could be expected during the relatively short period of time between pre-CPB and CPB biopsies is uncoupling of the receptor, which we assessed by agonist-stimulated adenylyl cyclase activity. Desensitization of this type can be expressed in different forms in these assays, the two most common being either a change in the maximal isoproterenol-stimulated activity or a shift in isoproterenol dose-response curve to the right with or without a change in the maximal. '6'17 When a small amount of sample is available, a single submaximal agonist concentration suffices for the detection of such a shift. 45 We found that CPB induces a decrease in both 100 ,uM and 500 nM isoproterenol-stimulated adenylyl cyclase activities, revealing both a decrease in the maximal agonist stimulatory capacity and a shift in the dose-response curve. These were completely reversed 30 minutes post-CPB, a time course typical of that found during resensitization. It should be noted that the timing of the CPB sample was actually after 25 minutes of rewarming (just before discontinuation of CPB); desensitization may be even more profound if assessed immediately before rewarming. The CPB time point chosen is appropriate clinically, however, because it is during discontinuation of CPB (a time point of maximal stress on the myocardium) that functional PARs are required. We also found that zinterol (a relatively selective f,2AR agonist) -stimulated adenylyl cyclase activities were depressed during CPB. This implies that of the PlAR subtypes, f32AR responses are specifically depressed. However, given that zinterol is not totally selective for f,2ARs and that it is only a partial ,l2AR agonist, we cannot conclude that only the 3,2AR subtype undergoes this desensitization during CPB.
The ,BAR desensitization noted during CPB did not appear to be related to a loss of myocardial flAR. At the CPB time point, the apparent decrease in PAR density was not statistically significant. Notably, however, at the post-CPB time point, a clear decrease in PAR density was found. Because no alterations in agonist-stimulated adenylyl cyclase activities were found at this time point, it appears that this loss of receptor density may be a second mechanism only beginning to be invoked at this time point. This is consistent with the usual time course of receptor downregulation, with -3-6 hours of agonist exposure being typical for significant changes, and may reflect continued elevation of plasma catecholamine levels after CPB. That a mild decrease in receptor number causes no alteration in agonist-stimulated adenylyl cyclase is not altogether unexpected. This implies that some "spare receptors" are present and that their loss does not significantly affect the overall response. It is also possible that functional desensitization of myocardial /3ARs may be more related to elevated catecholamines locally than systemically. As described in the introduction, during CPB (specifically aortic crossclamping) the myocardium is cooled, arrested, and deprived of its native blood flow. Under similar conditions, release of NE has been demonstrated from anoxic, isolated hearts,9-12 and cooling maintains elevated catecholamines in ischemic myocardium. 13,'4 We also assessed whether any changes in ,AR J31ARs and f,2ARs may have different downregulatory patterns has been suggested. 46 We found no change, however, in the relative proportion of /,8AR: f32AR. When individual 81AR and 3,2AR densities were determined (see "Results" and Figure 4 ), both subtypes appeared to be decreased at the post-CPB time point. These decreases were small and did not result in a significant decrease at the post-CPB time point (Figure 4 ). The total receptor density, however, representing the sum of both f31AR and ,82AR, was significantly decreased at this time point.
These data provide evidence for early downregulation of the ,BARs, but (as noted above) this may represent only a loss of cell surface 8ARs and not a decrease in the entire cellular complement of ,BAR.
In addition, ,1AR and f,2AR subtypes decreased to the same degree. The overall effect of either sequestration or downregulation, however, is presumably the same-a decrease in the number of available ,3ARs to bind agonist and to couple to G,. Our methods, of course, do not allow for assessment of the cellular distribution of ,AR subtypes. It should be noted, however, that autoradiographic studies of transmyocardial canine LV have shown that myocytes possess both ,81 and /32ARs, whereas small arterioles contain almost exclusively f82ARs.4' Figure 6 summarizes our working model of the effects of CPB on cardiac pARs based on the current study. Desensitization of ,BARs occurs during CPB, as evidenced by a decrease in agonist-stimulated adenylyl cyclase in membranes from the pre-CPB biopsy samples to the CPB biopsy samples. The latter time point represents the critical period just before weaning from CPB. Recovery occurs by at least 30 minutes after CPB is discontinued, the time of the post-CPB biopsy. The processes involved in downregulation of fAR number, known to require several hours, are initiated from the onset of CPB. Downregulation, which was minimal at the CPB time point, is clearly present at the post-CPB time point.
Our findings of desensitization of LV ,JARs during CPB have important clinical relevance. Discontinuation of CPB is a critical event during cardiac surgery. It is during this time period that flAR-mediated myocardial inotropic and chronotropic dysfunction (which is often relatively refractory to endogenous or infused catecholamines) is found, potentially leading to difficulty in weaning from CPB after completion of cardiac surgery. Although 15% l3AR desensitization upon termination of CPB represents a relatively small percentage of overall myocardial ,AR function, it is important to recognize that these experiments were performed in healthy dogs with normal hearts. Patients who require cardiac surgery usually have ischemic myocardial disease or valvular heart disease, and many of these patients have depressed myocardial function. A 15% decrease in flAR function in these patients upon termination of CPB may have important and significant implications regarding their ability to be weaned from CPB. We also found a decrease in ,lAR density in post-CPB biopsies. Although this was not associated with desensitization, it suggests that receptor downregulation in response to prolonged exposure to catecholamines experienced during the entire period is under way. Whether this continues into the immediate postoperative period is unknown.
